Predicting severity of acute pancreatitis

Current Gastroenterology Reports

Volumn 9, Issue 2, 2007, Pages 107-115

  Rau, Bettina M ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CARBOXYPEPTIDASE B; INTERLEUKIN 6; INTERLEUKIN 8; PANCREATIC ELASTASE; PROCALCITONIN; SERUM AMYLOID A; TRYPSINOGEN ACTIVATION PEPTIDE;

ABDOMINAL PRESSURE; ACUTE PANCREATITIS; AGE; APACHE; BODY MASS; COMORBIDITY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; HUMAN; MORTALITY; MULTIPLE ORGAN FAILURE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PANCREAS FUNCTION TEST; PANCREAS NECROSIS; PARALYSIS; PROGNOSIS; REVIEW; RISK FACTOR;

APACHE; BLOOD COAGULATION DISORDERS; CALCITONIN; CYTOKINES; HUMANS; LEUKOCYTE ELASTASE; MULTIPLE ORGAN FAILURE; PANCREATITIS; PEPTIDES; PROTEIN PRECURSORS; SERUM AMYLOID A PROTEIN; SEVERITY OF ILLNESS INDEX;

EID: 34247468896     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-007-0004-5     Document Type: Review

References (68)

1. Sarles H: Proposal adopted unanimously by the participants of the symposium on pancreatitis at Marseille, 1963. Bibl Gastroenterol 1965, 7:VII-VIII.
2. Bradley EL III: A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Arch Surg 1993, 128:586-590.
3. Lankisch PG, Schirren CA: Increased body weight as a prognostic parameter for complications in the course of acute pancreatitis. Pancreas 1990, 5:626-629.
4. Martinez J, Johnson CD, Sanchez-Paya J, et al.: Obesity is a definitive risk factor of severity and mortality in acute pancreatitis: an updated meta-analysis. Pancreatology 2006, 6:206-209.
5. Leppaniemi A, Kemppainen E: Recent advances in the surgical management of necrotizing pancreatitis. Curr Opin Crit Care 2005, 11:349-352.
6. Tao HQ, Zhang JX, Zou SC: Clinical characteristics and management of patients with early acute severe pancreatitis: experience from a medical center in China. World J Gastroenterol 2004, 10:919-921.
7. De Waele JJ, Hoste E, Blot SI, et al.: Intra-abdominal hypertension in patients with severe acute pancreatitis. Crit Care 2005, 9:R452-R457.
8. Isenmann R, Rau B, Beger HG: Early severe acute pancreatitis: characteristics of a new subgroup. Pancreas 2001, 22:274-278.
9. Buter A, Imrie CW, Carter CR, et al.: Dynamic nature of early organ dysfunction determines outcome in acute pancreatitis. Br J Surg 2002, 89:298-302.
10. Johnson CD, Abu-Hilal M: Persistent organ failure during the first week as a marker of fatal outcome in acute pancreatitis. Gut 2004, 53:1340-1344.
11. Poves Prim I, Fabregat Pous J, Garcia Borobia FJ, et al.: Early onset of organ failure is the best predictor of mortality in acute pancreatitis. Rev Esp Enferm Dig 2004, 96:705-713.
12. Rau BM, Bothe A, Kron M, Beger HG: Role of early multisystem organ failure as major risk factor for pancreatic infections and death in severe acute pancreatitis. Clin Gastroenterol Hepatol 2006, 4:1053-1061.
13. Mofidi R, Duff MD, Wigmore SJ, et al.: Association between early systemic inflammatory response, severity of multiorgan dysfunction and death in acute pancreatitis. Br J Surg 2006, 93:738-744.
14. Le Mee J, Paye F, Sauvanet A, et al.: Incidence and reversibility of organ failure in the course of sterile or infected necrotizing pancreatitis. Arch Surg 2001, 136:1386-1390.
15. Flint R, Windsor JA: Early physiological response to intensive care as a clinically relevant approach to predicting the outcome in severe acute pancreatitis. Arch Surg 2004, 139:438-443.
16. Satoh A, Miura T, Satoh K, et al.: Human leukocyte antigen-DR expression on peripheral monocytes as a predictive marker of sepsis during acute pancreatitis. Pancreas 2002, 25:245-250.
17. Mentula P, Kylanpaa-Back ML, Kemppainen E, et al.: Decreased HLA (human leucocyte antigen)-DR expression on peripheral blood monocytes predicts the development of organ failure in patients with acute pancreatitis. Clin Sci (Lond) 2003, 105:409-417.
18. Ho YP, Sheen IS, Chiu CT, et al.: A strong association between down-regulation of HLA-DR expression and the late mortality in patients with severe acute pancreatitis. Am J Gastroenterol 2006, 101:1117-1124.
19. Kylanpaa ML, Mentula P, Kemppainen E, et al.: Monocyte anergy is present in patients with severe acute pancreatitis and is significantly alleviated by granulocyte-macrophage colony-stimulating factor and interferon-gamma in vitro. Pancreas 2005, 31:23-27.
20. Leger L, Chiche B, Louvel A: Pancreatic necrosis and acute pancreatitis. World J Surg 1981, 5:315-317.
21. Jimenez H, Aldrete JS: Clinical implications derived from the morphological classification of 89 patients with acute pancreatitis. J Clin Gastroenterol 1983, 5:137-142.
22. Beger HG, Bittner R, Block S, Buchler M: Bacterial contamination of pancreatic necrosis. A prospective clinical study. Gastroenterology 1986, 91:433-438.
23. Uhl W, Warshaw A, Imrie C, et al.: IAP guidelines for the surgical management of acute pancreatitis. Pancreatology 2002, 2:565-573.
24. UK guidelines for the management of acute pancreatitis. Gut 2005, 54(Suppl 3) 1-9.
25. Zhu AJ, Shi JS, Sun XJ: Organ failure associated with severe acute pancreatitis. World J Gastroenterol 2003, 9:2570-2573.
26. Kong L, Santiago N, Han TQ, Zhang SD: Clinical characteristics and prognostic factors of severe acute pancreatitis. World J Gastroenterol 2004, 10:3336-3338.
27. Perez A, Whang EE, Brooks DC, et al.: Is severity of necrotizing pancreatitis increased in extended necrosis and infected necrosis? Pancreas 2002, 25:229-233.
28. Halonen KI, Pettila V, Leppaniemi AK, et al.: Multiple organ dysfunction associated with severe acute pancreatitis. Crit Care Med 2002, 30:1274-1279.
29. Runzi M, Niebel W, Goebell H, et al.: Severe acute pancreatitis: nonsurgical treatment of infected necroses. Pancreas 2005, 30:195-199.
30. Arvanitakis M, Delhaye M, De Maertelaere V, et al.: Computed tomography and magnetic resonance imaging in the assessment of acute pancreatitis. Gastroenterology 2004, 126:715-723.
31. Larvin M, McMahon MJ: APACHE-II score for assessment and monitoring of acute pancreatitis. Lancet 1989, 2:201-205.
32. Marshall JC, Cook DJ, Christou NV, et al.: Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 1995, 23:1638-1652.
33. Vincent JL, de Mendonca A, Cantraine F, et al.: Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med 1998, 26:1793-1800.
34. Halonen KI, Leppaniemi AK, Lundin JE, et al.: Predicting fatal outcome in the early phase of severe acute pancreatitis by using novel prognostic models. Pancreatology 2003, 3:309-315.
35. Rau BM, Kemppainen E, Bassi C, et al.: Assessment of major complications and overall prognosis by the SOFA-, APACHEII- and MOF-Score in severe acute pancreatitis: Results of an international multicenter study [abstract]. Pancreatology 2005, 5:76.
36. Trapnell JE: The natural history and prognosis of acute pancreatitis. Ann R Coll Surg Engl 1966, 38:265-287.
37. Rau B, Schilling MK, Beger HG: Laboratory markers of severe acute pancreatitis. Dig Dis 2004, 22:247-257.
38. Borgstrom A, Appelros S, Muller CA, et al.: Role of activation peptides from pancreatic proenzymes in the diagnosis and prognosis of acute pancreatitis. Surgery 2002, 131:125-128.
39. Gudgeon AM, Heath DI, Hurley P, et al.: Trypsinogen activation peptides assay in the early prediction of severity of acute pancreatitis. Lancet 1990, 335:4-8.
40. Tenner S, Fernandez-del Castillo C, Warshaw A, et al.: Urinary trypsinogen activation peptide (TAP) predicts severity in patients with acute pancreatitis. Int J Pancreatol 1997, 21:105-110.
41. Neoptolemos JP, Kemppainen EA, Mayer JM, et al.: Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study. Lancet 2000, 355:1955-1960.
42. Johnson CD, Lempinen M, Imrie CW, et al.: Urinary trypsinogen activation peptide as a marker of severe acute pancreatitis. Br J Surg 2004, 91:1027-1033.
43. Appelros S, Petersson U, Toh S, et al.: Activation peptide of carboxypeptidase B and anionic trypsinogen as early predictors of the severity of acute pancreatitis. Br J Surg 2001, 88:216-221.
44. Muller CA, Appelros S, Uhl W, et al.: Serum levels of procarboxypeptidase B and its activation peptide in patients with acute pancreatitis and non-pancreatic diseases. Gut 2002, 51:229-235.
45. Saez J, Martinez J, Trigo C, et al.: Comparative study of the activation peptide of carboxypeptidase B and trypsinogen as early predictors of the severity of acute pancreatitis. Pancreas 2004, 29:e9-e14.
46. Mayer JM, Raraty M, Slavin J, et al.: Serum amyloid A is a better early predictor of severity than C-reactive protein in acute pancreatitis. Br J Surg 2002, 89:163-171.
47. Wilson C, Heads A, Shenkin A, Imrie CW. C-reactive protein, antiproteases and complement factors as objective markers of severity in acute pancreatitis. Br J Surg 1989, 76:177-181.
48. Mentula P, Kylanpaa ML, Kemppainen E, et al.: Early prediction of organ failure by combined markers in patients with acute pancreatitis. Br J Surg 2005, 92:68-7S.
49. Rau B, Steinbach G, Baumgart K, et al.: Serum amyloid A versus C-reactive protein in acute pancreatitis: clinical value of an alternative acute-phase reactant. Crit Care Med 2000, 28:736-742.
50. Mayer J, Rau B, Gansauge F, Beger HG: Inflammatory mediators in human acute pancreatitis: clinical and pathophysiological implications. Gut 2000, 47:546-552.
51. Brivet FG, Emilie D, Galanaud P: Pro- and anti-inflammatory cytokines during acute severe pancreatitis: an early and sustained response, although unpredictable of death. Parisian Study Group on Acute Pancreatitis. Crit Care Med 1999, 27:749-755.
52. Chen CC, Wang SS, Lee FY, et al.: Proinflammatory cytokines in early assessment of the prognosis of acute pancreatitis. Am J Gastroenterol 1999, 94:213-218.
53. Dugernier TL, Laterre PF, Wittebole X, et al.: Compartmentalization of the inflarnmatory response during acute pancreatitis: correlation with local and systemic complications. Am J Respir Crit Care Med 2003, 168:148-157.
54. Stimac D, Fisic E, Milic S, et al.: Prognostic values of IL-6, IL-8, and IL-10 in acute pancreatitis. J Clin Gastroenterol 2006, 40:209-212.
55. Pezzilli R, Billi P, Miniero R, et al.: Serum interleukin-6, interleukin-8, and beta 2-microglobulin in early assessment of severity of acute pancreatitis. Comparison with serum C-reactive protein. Dig Dis Sci 1995, 40:2341-2348.
56. Rau B, Steinbach G, Gansauge F, et al.: The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis. Gut 1997, 41:832-840.
57. Gross V, Scholmerich J, Leser HG, et al.: Granulocyte elastase in assessment of severity of acute pancreatitis. Comparison with acute-phase proteins C-reactive protein, alpha 1-antitrypsin, and protease inhibitor alpha 2-macroglobulin. Dig Dis Sci 1990, 35:97-105.
58. Viedma JA, Perez-Mateo M, Agullo J, et al.: Inflammatory response in the early prediction of severity in human acute pancreatitis. Gut 1994, 35:822-827.
59. Dominguez-Munoz JE, Carballo F, Garcia MJ, et al.: Clinical usefulness of polymorphonuclear elastase in predicting the severity of acute pancreatitis: results of a multicenter study. BR J Surg 1991, 78:1230-1234.
60. Dominguez-Munoz JE, Villanueva A, Larino J, et al.: Accuracy of plasma levels of polymorphonuclear elastase as early prognostic marker of acute pancreatitis in routine clinical conditions. Eur J Gastroenterol Hepatol 2006, 18:79-83.
61. Maeda K, Hirota M, Ichihara A, et al.: Applicability of disseminated intravascular coagulation parameters in the assessment of the severity of acute pancreatitis. Pancreas 2006, 32:87-92.
62. Radenkovic D, Bajec D, Karamarkovic A, et al.: Disorders of hemostasis during the surgical management of severe necrotizing pancreatitis. Pancreas 2004, 29:152-156.
63. Simon L, Gauvin F, Amre DK, et al.: Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 2004, 39:206-217.
64. Rau B, Kruger CM, Schilling MK: Procalcitonin: improved biochemical severity stratification and postoperative monitoring in severe abdominal inflammation and sepsis. Langenbecks Arch Surg 2004, 389:134-144.
65. Kylanpaa-Back ML, Takala A, Kemppainen EA, et al.: Procalcitonin, soluble interleukin-2 receptor, and soluble E-selectin in predicting the severity of acute pancreatitis. Crit Care Med 2001, 29:63-69.
66. Kylanpaa-Back ML, Takala A, Kemppainen E, et al.: Procalcitonin strip test in the early detection of severe acute pancreatitis. Br J Surg 2001, 88:222-227.
67. Rau B, Kemppainen E, Gumb A, et al.: Early assessment of pancreatic infections and overall prognosis in severe acute pancreatitis by procalcitonin (PCT): A prospective international multicenter study Ann Surg 2007, 245, in press.
68. Purkayastha S, Chow A, Athanasiou T, et al.: Does serum procalcitonin have a role in evaluating the severity of acute pancreatitis? A question revisited. World J Surg 2006, 30:1713-1721.